AI Articles and Analysis about Research and development

Explore articles and reports related to artificial intelligence for research and development, including drug development, discovery, legal research, and more.

UNICRI on responsible AI criteria and other tool kits@2x-min

UNICRI-Approved Responsible AI Toolkits for Law Enforcement

The United Nations Interregional Crime and Justice Research Institute (UNICRI) was established in 1968 as an autonomous institution in response to a United Nations resolution urging expanded crime prevention and criminal justice activities. UNICRI's mission is to advance justice, crime prevention, security, and the rule of law to support peace, human rights, and sustainable development. 

final-updated-Approaching Life Sciences and Retail Challenges from a Data Perspective – with Alberto Rizolli of V7

Approaching Life Sciences and Retail Challenges from a Data Perspective – with Alberto Rizzoli of V7

Problems in different industries can look quite similar when looked at from the perspective of data. Though diverse business problems originate from distinct domains and needs, they often share a common thread and solution. 

AI at Takeda@1x-min

Artificial Intelligence at Takeda Pharmaceuticals

Takeda Pharmaceuticals is a 240-year-old, leading biopharmaceutical company headquartered in Tokyo, Japan, with a global hub in Cambridge, Massachusetts. The company has a global presence, operating in more than 80 countries across North America, Europe and Asia.

Generative AI Adoption Challenges From a Data Perspective – with Ted Kwartler of Data Robot and Tsavo Knott of Pieces@1x

Generative AI Adoption Challenges From a Data Perspective – with Ted Kwartler of Data Robot and Tsavo Knott of Pieces

This interview analysis is sponsored by Pieces and was written, edited and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

Future of Drug Targeting – Lilly @2x-1-min

The Future of Drug Targeting and Clinical Development with Generative AI Tools – with Ramesh Durvasula of Eli Lilly

Lily is a pharmaceutical giant with a legacy dating back to its founding in 1876 by Colonel Eli Lilly. The company engages more than 9600 employees in research and development, with clinical research conducted in more than 55 countries. As of 2022, the company clocked a revenue of $28,541.4 million and made a net income of $6,244.8 million. 

AI at GSK@2x-min

Artificial Intelligence at GSK

GlaxoSmithKline (GSK) is a multinational pharmaceutical company headquartered in Brentford, UK. The company operates in over 150 countries. GSK offers a wide range of pharmaceutical products, vaccines, and consumer healthcare products, including over-the-counter medications, oral care and nutritional products.

AI at McKesson@2x-min

Artificial Intelligence at McKesson – Three Use Cases

Founded in 1833 and headquartered in Irving, Texas, since 2019, McKesson is a leading distributor of pharmaceuticals and medical supplies. They also provide health information technology and care management tools.

AI at Cardinal Health@2x-min

Artificial Intelligence at Cardinal Health – Two Use Cases

Cardinal Health is a global healthcare services company with a rich history and a strong focus on providing integrated solutions to the healthcare industry. Established in 1971, the company has become a leading player in the healthcare sector, offering a wide range of products, services, and technologies to enhance patient care, optimize supply chain efficiency, and drive value-based outcomes.

Research and development

Explore articles and reports related to artificial intelligence for research and development, including drug development, discovery, legal research, and more.